Robert Pfeffer
Papers
1
Total Citations
14
H-Index
1
About
Robert Pfeffer is a leading figure in radiation oncology, with his research primarily focused on stereotactic body radiotherapy (SBRT) for prostate cancer. His major contributions center on advancing high-dose, "HDR-like" SBRT protocols, demonstrating their long-term efficacy and safety. Pfeffer’s most-cited work, a mature, multi-institutional clinical trial with 259 patients across 18 centers, reports 10-year PSA outcomes—a rare and valuable dataset in the field. This study, with 14 citations, provides critical evidence that prostate SBRT can achieve durable biochemical control comparable to traditional fractionated regimens, while offering a more convenient treatment schedule. His work has helped solidify SBRT as a standard option for low- and intermediate-risk prostate cancer, influencing clinical guidelines globally. Pfeffer’s ability to coordinate large-scale, collaborative trials underscores his leadership in translating innovative radiotherapy techniques into practice. For students and researchers, his research exemplifies how rigorous, long-term follow-up can validate emerging technologies, making him a key voice in the evolution of precision radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1